🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Biphenotypicii Hamaa › North Dakota

Qorannoo klinikaalii Leukemia Biphenotypicii Hamaa North Dakota keessatti

Qorannoo 3 Leukemia Biphenotypicii Hamaa f North Dakota keessatti hirmaatuu jiru.

Magaalota North Dakota keessatti

Takkalaa qorannoo (Ingiliffa)

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Sanford Broadway Medical Center, Fargo
Namoota walitti qabaa jiraSadarkaa 3
365 Days – 25 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03959085

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.